Phenominer Database Results (5 results)

 
 
Table "column sort" updates the order of the bars in the chart.
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Method Notes Record ID Study ID
ACI/SegHsd mammary tumor number 17 beta-estradiol (27.5 mg) (between 193 and 199 days) Schaffer BS, et al., Cancer Res. 2006 Aug 1;66(15):7793-800 mammary gland integrity trait female 143.0 days-259.0 days 22 8.8 null 1.4 6.57 manual palpation method 0.0 crystalline implant 11382 81
ACI/SegHsd mammary tumor number 17 beta-estradiol (27.5 mg) (for 196 days) Kurz SG, et al., Endocrinology. 2008 Apr 17 mammary gland integrity trait female 259.0 days 21 7.0 null 1.16 5.3 necropsy 11368 75
ACI/SegHsd mammary tumor number control condition Kurz SG, et al., Endocrinology. 2008 Apr 17 mammary gland integrity trait female 259.0 days 4 0.0 null necropsy 11367 75
ACI/SegHsd mammary tumor number 17 beta-estradiol (27.5 mg) (between 99 and 197 days) Shull JD, et al., Carcinogenesis. 1997 Aug;18(8):1595-601 mammary gland integrity trait female 160.0 days-260.0 days 20 5.6 null necropsy 0.0 tumor size reach 1-1.5 cm 11377 76
ACI/SegHsd mammary tumor number 17 beta-estradiol (27.5 mg) (between 144 and 195 days) Shull JD, et al., Endocrinology 2001 Dec;142(12):5124-30 mammary gland integrity trait female 203.0 days-264.0 days 34 3.9 null 0.6 3.5 manual palpation method 0 11752 144